Supplementary Methods
General Considerations. All commercially available compounds were purchased and used as received. Synthesis of 2-(4-amino-2-ethoxymethyl-1H-imidazo{4,5-c}quinolin-1-yl)ethaneamine (Compound A) was completed following previously reported synthetic route [1, 2] . Synthesis of 1-(4-aminobutyl)-2-(ethoxymethyl)-1H-imidazo{4,5-c}quinolin4-amine (Compound B) was completed following previously reported synthetic route [2, 3] . 1-(4-(Aminomethyl)benzyl)-2-butyl-1H-imidazo{4,5-c}quinolin-4-ylamine (Compound C) was obtained from R&S Chemicals, Inc. (Kannapolis, NC). Reaction mixtures were purified using a Biotage ® SNAP Bio C18 300 Å 10 g on a Biotage ® Isolera with a gradient composed of water (0.1% formic acid) and acetonitrile (0.1% formic acid) for reversed-phase chromatography. P1 is a normal phase column chromatography solvent freshly prepared mixture composed of water, methanol, and acetonitrile mixed in a 1:1:1 ratio. A note of caution on the use of P1, this solvent mixture should never be stored for prolonged periods of time as the decomposition of acetonitrile to acetamide is catalyzed by water/methanol. 1 H and 13 C NMR spectra were recorded on a Bruker AC-400 MHz spectrometer. ESI mass spectra were recorded using a Waters 3100 Mass Detector.
Synthesis of 2. 1-Adamantaneacetic acid (124 mg, 0.69 mmol), EDC (147 mg, 0.950 mmol), NHS (79 mg, 0.69 mmol) were dissolved in DMF (5 mL) with N,N-diisopropylethylamine (2 mL). To this Compound A (201 mg, 0.63 mmol) was added and the reaction was allowed to proceed for 20 minutes at room temperature. After which, the reaction was concentrated under reduced pressure. The crude reaction mixture was purified via reversed-phase chromatography. Fraction of similar purity were combined and concentrated to yield the desired product 2 (9 mg, 3 % yield). MS (ESI) calculated for C 27 H 35 N 5 O 2 , m/z 461.28, found 462 (M + H) + .
Synthesis of 3. 1-Adamantaneacetic acid (13.6 mg, 0.07 mmol) and and HOBt (9.5 mg, 0.07 mmol) were dissolved in DMF (1.0 mL) with N,N-diisopropylethylamine (0.25 mL). To this resiquimod (20 mg, 0.06 mmol, SelleckChem) in DMF (1 mL) was added and the reaction was allowed to proceed for 24 hours at 50 C. After which, the reaction was concentrated under reduced pressure. The crude reaction mixture was purified via normal-phase chromatography starting with EtOAc with a gradient increasing to completely P1. Fraction of similar purity were combined and concentrated to yield the desired product 3 (4.5 mg, 13 % yield). 
Synthesis of 9.
Compound C (5.6 mg, 0.02 mmol) was dissolved in acetic anhydride (0.1 mL) with N,N-diisopropylethylamine (0.1 mL). The reaction was allowed to proceed for 30 minutes at room temperature. After which, the reaction was concentrated under reduced pressure to yield the desired product 9 (6.2 mg, 99 % yield). MS (ESI) calculated for C 24 H 27 N 5 O, m/z 401.22, found 402 (M + H) + .
Synthesis of 10. 1-Adamantaneacetic acid (28 mg, 0.14 mmol), HATU (53 mg, 0.14 mmol), and NHS (17 mg, 0.14 mmol) was dissolved in DMF (5 mL) with N,N-diisopropylethylamine (0.1 mL) under Ar. After 30 mins, Compound C (40 mg, 0.11 mmol) dissolved in minimal DMF and were added and the reaction was allowed to proceed for 30 minutes at room temperature. After which, the reaction was concentrated under reduced pressure. The crude reaction mixture was purified via reversed-phase chromatography. Fraction of similar purity were combined and concentrated to yield the desired product 10 (59 mg, 78 % yield Figure S8 ).
Visualization of drug binding. Visualization of R848 derivative interactions with TLR7 (protein databank number: 5gmh) was performed with the aid of PyMOL software package [4] . The crystal structure of monkey TLR7-R848 was chosen as a surrogate for the human receptor due to the high quality data available and conservation of protein structure across species. TLR7 exists in vivo as a dimeric species; however, the PDB data file used for drug optimization is a monomer projection and requires workup to display the dimeric component prior to analysis. NMR and HPLC (at both 250 and 315 nm) to be spectroscopically pure (>95%).
